Intellective Bio is a CDMO focusing on biopharmaceutical process development and large-scale production.
Intellectual Bio specializes in the fields of biopharmaceutical development, commercial production, and Biologics Development. IntellectiveBio is equipped with technical platforms including Protein Science, Cell Engineering, Cell Culture, Protein Purification, Analytical Science, Formulation Development
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 5, 2022 | Series C | ¥500M | 1 | Gaorong Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaorong Capital | Yes | Series C |